Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited HCV r...
Saved in:
Main Authors: | Chang Ho Lee (Author), Soo-Han Lee (Author), Ji Hyun Kim (Author), Yook-Hwan Noh (Author), Gyu-Jeong Noh (Author), Seong-Wook Lee (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells
by: Ji Hyun Kim, et al.
Published: (2019) -
Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element
by: Alfredo Berzal-Herranz, et al.
Published: (2011) -
Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
by: Hu K, et al.
Published: (2020) -
Recent progress of aptamer‒drug conjugates in cancer therapy
by: Jiaxuan He, et al.
Published: (2023) -
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors
by: Jehad Hamdy, et al.
Published: (2022)